Display options
Share it on
Full text links
Atypon Free PMC Article

Infect Immun. 1985 Oct;50(1):160-8. doi: 10.1128/iai.50.1.160-168.1985.

Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.

Infection and immunity

A D Nickol, P F Bonventre

PMID: 2931376 PMCID: PMC262151 DOI: 10.1128/iai.50.1.160-168.1985
Free PMC Article

Abstract

Visceral leishmaniasis is one of several parasitic diseases of humans characterized by immune suppression. A murine model of disseminated leishmaniasis utilizing inbred strains of specific genetic constitution was used to study the mechanisms of immunosuppression elicited during the course of infection. Resistant (Lshr) and susceptible (Lshs) strains of mice were challenged with amastigotes of Leishmania donovani and evaluated as to immune status at intervals between 2 and 40 weeks after challenge. The proliferative responses of splenic lymphocytes to T-cell mitogens, a B-cell mitogen, and parasite antigens were measured to evaluate the relative immune status of parasitized mice and noninfected control mice. Lymphocytes from resistant C3Heb/FeJ (C3H) mice responded normally to concanavalin A and phytohemagglutinin throughout the course of infection. Parasite antigen responses appeared 2 weeks after challenge of C3H mice and remained vigorous for periods up to 6 months. In contrast, immune suppression during infection was profound in both the curing (C57B1/10) and noncuring (B10.D2) phenotypes of Lshs congenic mice. Both Lshs strains developed severe infection as evidenced by high parasite burdens in the liver and spleen 4 to 5 weeks after challenge; splenic lymphocytes taken from these mice between 2 and 8 weeks became increasingly unresponsive to the T-cell mitogens as well as to parasite antigens. The noncuring B10.D2 mice which suffered chronic infection continued to be suppressed for as long as 40 weeks. C57B1/10 (curing) mice, in contrast, cleared infection between 12 and 16 weeks. After spontaneous recovery or elimination of parasites by antimonial drug therapy, the response of spleen cells to T-cell mitogens or parasite antigens were restored to normal. The spleen cells from the Lshs strains of mice obtained during the height of infection suppressed the proliferative responses of spleen cells from their uninfected counterparts upon cocultivation in vitro. Removal of adherent cells from the suppressive spleen cell populations restored normal mitogen responses. On the basis of adherence characteristics, phagocytosis, and morphology, the suppressor was identified as a macrophage population which appears to be responsible for a nonspecific immunosuppression of Lshs mice with significant parasite burdens of L. donovani.

Similar articles

References

  1. J Immunol. 1978 Jun;120(6):2027-32 - PubMed
  2. Clin Exp Immunol. 1977 Oct;30(1):130-40 - PubMed
  3. Cell Immunol. 1979 Jul;45(2):377-88 - PubMed
  4. Clin Exp Immunol. 1979 Jul;37(1):7-14 - PubMed
  5. Nature. 1980 Jan 3;283(5742):72-4 - PubMed
  6. J Immunol. 1980 Feb;124(2):983-8 - PubMed
  7. J Immunol. 1980 Aug;125(2):749-54 - PubMed
  8. Dent Dimens. 1980 Jun;13(2):21-2 - PubMed
  9. Infect Immun. 1981 Sep;33(3):918-26 - PubMed
  10. Proc Soc Exp Biol Med. 1982 Feb;169(2):165-74 - PubMed
  11. J Immunol. 1982 Nov;129(5):2202-5 - PubMed
  12. Nature. 1982 Jun 10;297(5866):510-1 - PubMed
  13. J Immunol. 1982 Jul;129(1):344-50 - PubMed
  14. Cell Immunol. 1982 Jul 15;71(1):54-65 - PubMed
  15. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3466-9 - PubMed
  16. J Immunol. 1983 Sep;131(3):1487-91 - PubMed
  17. Infect Immun. 1984 Jan;43(1):32-7 - PubMed
  18. J Immunol. 1984 Jun;132(6):3120-5 - PubMed
  19. Immunology. 1984 Jul;52(3):417-22 - PubMed
  20. J Leukoc Biol. 1984 Nov;36(5):651-8 - PubMed
  21. Infect Immun. 1985 Oct;50(1):169-74 - PubMed
  22. Ann N Y Acad Sci. 1963 Dec 30;113:409-17 - PubMed
  23. Clin Exp Immunol. 1972 Nov;12(3):365-75 - PubMed
  24. Infect Immun. 1974 Jul;10(1):66-71 - PubMed
  25. J Immunol. 1975 Jan;114(1 Pt 1):206-10 - PubMed
  26. Cell Immunol. 1975 Jul;18(1):70-5 - PubMed
  27. J Immunol. 1975 Nov;115(5):1212-6 - PubMed
  28. Clin Exp Immunol. 1975 Oct;22(1):167-76 - PubMed
  29. J Immunol. 1976 May;116(5):1342-6 - PubMed
  30. Cell Immunol. 1977 Jan;28(1):22-35 - PubMed
  31. J Exp Med. 1977 Sep 1;146(3):665-72 - PubMed
  32. Clin Exp Immunol. 1977 Oct;30(1):119-29 - PubMed
  33. Infect Immun. 1979 Mar;23(3):893-902 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources